These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35383762)

  • 21. Insulin and glucagon responses to provocation with glucose and arginine in prepubertal children with thalassemia major before and after long-term blood transfusion.
    Soliman AT; el Banna N; alSalmi I; Asfour M
    J Trop Pediatr; 1996 Oct; 42(5):291-6. PubMed ID: 8936961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of gonadal status on body composition and bone mineral density in transfusion-dependent thalassemia.
    Wong P; Fuller PJ; Gillespie MT; Kartsogiannis V; Milat F; Bowden DK; Strauss BJ
    Osteoporos Int; 2014 Feb; 25(2):597-604. PubMed ID: 23903954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia.
    Vogiatzi MG; Autio KA; Schneider R; Giardina PJ
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1415-21. PubMed ID: 15526720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone mineral density in adult patients with major thalassaemia: our experience and a brief review of the literature.
    Izadyar S; Fazeli M; Izadyar M; Salamati P; Gholamrezanezhad A
    Endokrynol Pol; 2012; 63(4):264-9. PubMed ID: 22933161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mineral density in primarily preadolescent children with hemoglobin E/β-thalassemia with different severities and transfusion requirements.
    Nakavachara P; Weerakulwattana P; Pooliam J; Viprakasit V
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29789. PubMed ID: 35652568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalassemia bone disease: a 19-year longitudinal analysis.
    Wong P; Fuller PJ; Gillespie MT; Kartsogiannis V; Kerr PG; Doery JC; Paul E; Bowden DK; Strauss BJ; Milat F
    J Bone Miner Res; 2014 Nov; 29(11):2468-73. PubMed ID: 24764138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in the prevalence and severity of bone disease in thalassaemia.
    Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of low bone mass among adolescents with nontransfusion-dependent hemoglobin E/β-thalassemia and its relationship with anemia severity.
    Nakavachara P; Petchkul J; Jeerawongpanich K; Kiattisakthavee P; Manpayak T; Netsakulnee P; Chaichanwattanakul K; Pooliam J; Srichairatanakool S; Viprakasit V
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28801997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone - insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major.
    Soliman A; De Sanctis V; Yassin M; Abdelrahman MO
    Indian J Endocrinol Metab; 2014 Jan; 18(1):32-8. PubMed ID: 24701427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between chronic transfusion therapy and body composition in subjects with thalassemia.
    Fung EB; Xu Y; Kwiatkowski JL; Vogiatzi MG; Neufeld E; Olivieri N; Vichinsky EP; Giardina PJ;
    J Pediatr; 2010 Oct; 157(4):641-7, 647.e1-2. PubMed ID: 20547400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT; Yassin MA; De Sanctis V
    Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red Cell Alloantibodies in Thalassaemia Patients Who Received Ten or More Units of Transfusion.
    Sarkar SK; Shah MS; Begum M; Yunus AM; Aziz MA; Kabir AL; Khan MR; Rahman F; Rahman A
    Mymensingh Med J; 2019 Apr; 28(2):364-369. PubMed ID: 31086152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalassaemic osteopathy: a cross-sectional preliminary study from Sri Lanka.
    Dissanayake R; de Silva S; Lekamwasam S; Abeysekara G; Dissanayake VH
    J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):279-82. PubMed ID: 24129099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density in transfusion-dependent thalassemia patients and its associated factors in Southern Iran.
    Bordbar M; Omrani GR; Haghpanah S; Saki F; Karimi M; Zekavat O
    Arch Osteoporos; 2020 Sep; 15(1):148. PubMed ID: 32955681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone mineral density in children with relapsing nephrotic syndrome: A hospital-based study.
    Jesmin T; Al Mamun A; Rahman MA; Santa SM; Huque SS; Begum A; Roy RR; Rahman MH; Uddin GM
    Saudi J Kidney Dis Transpl; 2019; 30(6):1415-1422. PubMed ID: 31929289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary functions in Egyptian children with transfusion-dependent β-thalassemia.
    Abd El Hakeem AA; Mousa SMO; AbdelFattah MT; AbdelAziz AO; Abd El Azeim SS
    Transfus Med; 2019 Feb; 29(1):55-60. PubMed ID: 30779248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.
    Baldini M; Forti S; Marcon A; Ulivieri FM; Orsatti A; Tampieri B; Airaghi L; Zanaboni L; Cappellini MD
    Ann Hematol; 2010 Dec; 89(12):1207-13. PubMed ID: 20582415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 2-year prospective densitometric study on the influence of Fok-I gene polymorphism in young patients with thalassaemia major.
    Dimitriadou M; Christoforidis A; Fidani L; Economou M; Vlachaki E; Athanassiou-Metaxa M; Katzos G
    Osteoporos Int; 2016 Feb; 27(2):781-8. PubMed ID: 26275438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Iron Chelating Agents in Transfusion Dependent Thalassaemia Major Patients.
    Santra S; Bhattacharya A; Mukhopadhyay T; Agrawal D; Kumar S; Das P; Chakrabarty P
    Mymensingh Med J; 2015 Oct; 24(4):838-44. PubMed ID: 26620028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.